MEDICAL TOURISM WORKSHOPS
TUESDAY, 16 APRIL 2019
11:00am – 11:15pm – Welcome Address
Treatments Abroad Director, Ministry Of Health, Kuwait
11:15pm – 12:00pm – Panel Discussion:
Ace for Medical Travel
12:15pm – 1:00pm – Dubai Destination Branding: medical tourism stakeholders’ perception towards the GCC market
Dr Anil Bankar, PhD Medical Tourism, Strategic Planner & Consultant – Health Tourism, United Arab Emirates
According to the GCC Healthcare industry recent report, the GCC healthcare system has limited capacity and technology to treat diseases such as cancers, neurological disorders and cardiovascular diseases. This has started with locals travelling overseas for medical treatments. Medical tourism is an elemental part of economic diversification plans of the GCC countries and subsequently, has been receiving stimulus from the governments. Dubai and Abu Dhabi are at the forefront amongst the GCC nations in attracting medical tourists.
Dubai has super infrastructure and accessibility which is one of the essential factors of medical tourism. Near about 32 Nationalities do not require a VISA to enter the United Arab Emirates. In the year 2012 to 2015 Dubai has received 20 million visitors. There is a significant transformation in medical tourism. The number of medical tourists is growing in 2012. The Dubai Medical Tourism segment generated more than Dh1.4 billion for the emirate in 2016 and received 326,649 medical tourists. Dubai is projecting that over a half million medical tourists will be visiting Dubai by 2020.
1:00pm – 5:00pm – BREAK
5:15pm – 6:00pm – Customized 3D printed insoles
Benta Pharma Industries
Revolutionary orthotics are the result of unique cutting-edge technology, using the patented dynamic foot scan technology and biomechanical measurements (highly sensitive pressure plate combined with a 3D foot scanner), we analyses your gait.
Using this dynamic analysis, the expert generates a design which is then created by an HP 3D printer.
The result is a dynamic 3D orthotic insole which takes into account the shape of your foot and also support the different pressure zones and guide your gait in the right direction.
Foot related problems throw our whole body off balance, about 80% of human beings will face foot related problems at some point in life; Our dynamic 3D printed Benta insoles custom orthotics can help to relieve or prevent these problems.
Our insoles are made from high grade ultralight Polyamide, specially selected for the comfort of your feet.
Benta Orthotics last up to 3 times longer than traditional insoles
Keywords: Benta Fitstation Customized 3D Printed Insoles
5:40pm – 6:10pm – Premium Stem Cell Therapy in Malaysia
Wijenthiran Kunasekaran, Director, Stem Cell Therapy Asia
Stem cell therapy is an emerging treatment for a variety of degenerative diseases and conditions. Malaysia is a favoured destination for medical tourism including stem cell therapy because of its cultural diversity, excellent hospitality and world class medical facilities. Stem Cell Therapy Asia provides premium grade live human mesenchymal stem cells (MSCs) at passage 2 for a variety of degenerative diseases/conditions including osteoarthritis, stroke, type 2 diabetes and cardiovascular diseases. We partner with established healthcare providers and universities to deliver professional and innovative solutions for degenerative disorders. MSCs are produced at our EU GMP standard R&D and production facility.
Keywords: Regenerative Medicine, Mesenchymal Stem Cells, Degenerative Diseases, Malaysia
6:20pm – 7:00pm – What’s the Future Stem Cell Application for Orthopedics
Thomas Vangsness, Jr., M.D./ Medical director of Allure Cell Inc. / Board certified orthopedic Surgeon and Tenured Professor of orthopedic surgery at the Keck School of Medicine at University of Southern California, USA
A review of the small number of reported studies revealed a high degree of variability in placental cell types, placental tissue preparation, routes of administration, and treatment regimens, which prohibits making any definitive conclusions. Currently, the clinical use of placenta is limited to only commercial placental tissue allografts, as there are no placenta-derived biological drugs approved for the treatment of orthopaedic sports medicine conditions in the United States. However, this review shows that the application of placental cells or tissue allografts appears to be safe and has potential to improve outcomes for orthopaedic sports medicine indications.
Keywords: placenta; amniotic membrane; umbilical cord; stem cells; regenerative medicine